Zosano Pharma Corporation announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating loss was USD 7.972 million compared to USD 7.698 million a year ago. Net loss was USD 6.144 million compared to USD 7.895 million a year ago. Basic loss per share from continuing operations was USD 0.06 compared to USD 0.14 a year ago. For the half year, operating loss was USD 16.020 million compared to USD 16.294 million a year ago. Net loss was USD 14.286 million compared to USD 16.584 million a year ago. Basic loss per share from continuing operations was USD 0.13 compared to USD 0.36 a year ago.